A detailed history of Invesco Ltd. transactions in Seer, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 246,154 shares of SEER stock, worth $413,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246,154
Previous 107,232 129.55%
Holding current value
$413,538
Previous $208,000 124.52%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.54 - $2.09 $213,939 - $290,346
138,922 Added 129.55%
246,154 $467,000
Q4 2023

Feb 12, 2024

BUY
$1.47 - $2.22 $9,550 - $14,423
6,497 Added 6.45%
107,232 $208,000
Q3 2023

Nov 13, 2023

BUY
$2.18 - $5.52 $1,569 - $3,974
720 Added 0.72%
100,735 $222,000
Q2 2023

Aug 11, 2023

SELL
$3.16 - $4.96 $6,914 - $10,852
-2,188 Reduced 2.14%
100,015 $427,000
Q1 2023

May 12, 2023

BUY
$3.6 - $5.88 $220,698 - $360,473
61,305 Added 149.9%
102,203 $394,000
Q4 2022

Feb 13, 2023

SELL
$5.03 - $8.58 $5,668 - $9,669
-1,127 Reduced 2.68%
40,898 $237,000
Q3 2022

Nov 14, 2022

SELL
$7.7 - $13.31 $10,587 - $18,301
-1,375 Reduced 3.17%
42,025 $326,000
Q2 2022

Aug 15, 2022

BUY
$6.72 - $16.07 $38,418 - $91,872
5,717 Added 15.17%
43,400 $389,000
Q1 2022

May 16, 2022

BUY
$11.88 - $23.4 $251,772 - $495,916
21,193 Added 128.52%
37,683 $574,000
Q4 2021

Feb 14, 2022

BUY
$21.08 - $38.51 $4,026 - $7,355
191 Added 1.17%
16,490 $377,000
Q3 2021

Nov 15, 2021

BUY
$27.67 - $45.04 $450,993 - $734,106
16,299 New
16,299 $564,000
Q2 2021

Aug 17, 2021

SELL
$28.75 - $56.92 $2.03 Million - $4.02 Million
-70,584 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$38.67 - $84.06 $5 Million - $10.9 Million
-129,416 Reduced 64.71%
70,584 $3.53 Million
Q4 2020

Feb 16, 2021

BUY
$55.23 - $81.11 $11 Million - $16.2 Million
200,000 New
200,000 $11.2 Million

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $98.4M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.